Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 86 Warning: fopen(/home/virtual/pfmjournal/journal/upload/ip_log/ip_log_2023-05.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 88 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 89 Stages of renal artery stenosis: a hypothesis based on ultrasound findings: A narrative review
Precis Future Med Search


Precis Future Med > Volume 7(1); 2023 > Article
Park: Stages of renal artery stenosis: a hypothesis based on ultrasound findings: A narrative review


Current ultrasound (US) scanners can directly detect renal artery stenosis (RAS) in which the degree is the same irrespective of heart beat. Frequently, however, blood pressure or renal function is not improved because the stage of RAS is too late. Therefore, RAS should be early detected and thus the radiologists are familiar with US features of early, intermediate, and late RAS. Atherosclerosis is the most common etiology to RAS and begins inflammation from the intima of renal artery. Accordingly, we can hypothesize that there are multi-stages going to the final RAS. At early stage, RAS can be detected on diastolic phase alone. However, at intermediate stage, it begins to be seen on systolic phase and is more severe on diagnostic phase than that at early stage. Finally, at late stage, RAS is seen at the same degree regardless of heart beats because the stenosis is fixed due to fibrosis. The purpose of this review is to introduce a hypothesis on the stages of RAS, to show the renal artery US features of each stage, and to compare US and angiography in terms of RAS detection.


Renal artery stenosis (RAS) is a major cause of secondary hypertension and renal impairment [1-3]. Atherosclerosis is the most common etiology for RAS and usually involves the ostium and proximal artery [1]. This disease entity is a kind of inflammation that occurs when atherosclerotic plaques build up on the inside walls of the arteries [4,5]. The plaque is a sticky substance composed of fat, cholesterol, calcium, and other materials. As plaque accumulation increases, the arteries become hard and narrowed [4,5]. Accordingly, the early-stage of RAS is not clear on imaging examination, and visualization is achieved starting in the intermediate stage. At these stages, the size and shape of RAS are changeable according to the systolic and diastolic phases of heart beats. However, the size and shape of RAS are fixed regardless of heartbeat at the late-stage of RAS due to fibrosis.
Renal artery ultrasound (RAUS) shows high sensitivity for detecting RAS, but specificity is relatively low [6-11]. In addition, the detection ability of RAUS differs from that of arteriography. There has been no report demonstrating the cause of discrepancy between RAUS and arteriography. Moreover, because vascular intervention is limited in improving renal function in the late-stage of RAS [12-14], earlier detection is necessary for management.
Based on experience with numerous RAS cases, RAS does not occur in a single step but is a multi-step inflammatory disease. It is hypothesized that RAS sonographically consists of early, intermediate, and late stages according to the degree of atherosclerotic change. Accordingly, RAUS can show various imaging features according to disease stage.
From this point of view, we can hypothesize that RAUS can depict imaging features of RAS stages. There are rare studies reporting RAUS findings of each RAS stage. The purpose of this review is to introduce a hypothesis on the stages of RAS, to show the features of each stage, and to compare RAUS and angiography in terms of detecting RAS stages.


At early-stage RAS, stenosis begins to be seen at the diastolic phase of the heartbeat (Table 1). At this stage, atherosclerotic inflammation has not hardened and narrowed the intima of a renal artery. Because the RAS does not restrict the diameter of the artery at the systolic blood pressure, stenosis is not seen at the systolic phase. Therefore, RAS is seen only at diastolic phase because it begins to appear at low blood pressure of diastolic phase. Early-stage RAS also does not show high-speed blood flow through a stenotic lumen or post-stenotic turbulence flow. Accordingly, post-stenotic dilatation is minimal at this stage of RAS. Because renal ischemia is minimal, patients with early-stage RAS commonly are asymptomatic.
The early stage of RAS is difficult to detect because of its limited visualization only on diagnostic phase. To overcome this, RAUS is a suitable imaging modality because it can provide real-time imaging of diastolic phase as well as systolic phase. On color Doppler RAUS, a renal artery can be unremarkable at systolic phase but is narrowed on diastolic phase (Fig. 1). However, there is no sign of RAS on gray-scale or spectral Doppler RAUS.
Renal ultrasound (US) cannot detect the early-stage of RAS reliably, showing poor intra- and inter-observer agreement [15,16]. Transient and reversible narrowing of a renal artery at diastolic phase alone has minimal influence on intra-renal arterial hemodynamics. The ability of renal arteriography has not been reported in detecting early-stage RAS but seems to be poor due to markedly poor sensitivity (Table 2). However, further investigation is necessary to explain why early-stage RAS is difficult to depict with arteriography.


Intermediate-stage RAS is defined when a stenosis becomes visible on RAUS at systolic phase as well as at diastolic phase (Table 1). Development of atherosclerotic fibrosis at this stage can start to harden the wall of a renal artery. Accordingly, RAS can be visualized at systolic phase but is more apparent than at diastolic phase. The degree of RAS at diastolic phase progresses at the intermediate stage compared to that of the early stage. Post-stenotic dilatation begins to develop because of the turbulence caused by the high-speed of blood flow through the stenotic portion. Renal ischemia is more apparent at the intermediate stage, and renal function begins to decrease and blood pressure begins to increase. Patients with intermediate-stage RAS start to be symptomatic.
RAUS shows mild to moderate stenosis at systolic phase as well as at diastolic phase (Fig. 2). Color Doppler RAUS shows fast blood flow through the narrow lumen of the renal artery. Spectral Doppler US shows an increase in the systolic velocity of blood flow in RAS, although it barely exceeds 180 to 200 cm/sec [3,6,7,17,18]. In patients with unilateral intermediate-stage RAS, an involved artery experience higher velocity of blood flow than a non-involved artery. Contrast-enhanced RAUS also shows mild to moderate stenosis at systolic phase and moderate stenosis at diastolic phase.
Arteriography has relatively low sensitivity at intermediate-stage disease because of the mild stenosis compared to that at late-stage RAS (Table 2). Thus, it is not uncommon that arteriography is negative for intermediate-stage RAS even though RAUS is positive. Moreover, because renal artery catheterization hinders narrowing at systolic phase, it decreases the sensitivity for detecting intermediate RAS. Clinically, patients with intermediate RAS becomes symptomatic due to increased renal ischemia. Therefore, detecting RAS at the intermediate stage is very important for determining treatment planning. Early medication or intervention helps to improve treatment outcomes of RAS, when renal function still remains reversible. Radiologists should be aware that intermediate-stage RAS is not visible on arteriography but can be visualized on RAUS. Close observation or early treatment should be considered if RAUS is positive but arteriography is negative in patients with clinical suspicion of RAS.


Late-stage RAS is defined when stenosis is clearly seen at the same degree regardless of heartbeats (Table 1). At this stage, the degree of RAS is more severe than that at the intermediate stage and is the same at diastolic and systolic phases. Because atherosclerotic inflammation has progressed to near fibrosis, the wall of a renal artery is so hard or rigid. Post-stenotic dilatation at this stage is greater than that at the intermediate stage because of greater impact of the turbulent flow caused by the severe stenosis. Patients with late-stage RAS are symptomatic, experiencing poor renal function and uncontrolled hypertension [2,19].
Gray-scale RAUS can show RAS if the sonic window is suitable. Color Doppler US shows bright color-coded blood flow through the stenosis and turbulent flow in post-stenotic dilatation. Spectral Doppler US shows that the velocity of blood flow exceeds 180 to 200 cm/sec within the stenosis [3,6,7,17,18]. A reno-aorta ratio of peak systolic velocity of 3.5 or greater is another good indicator of RAS [8,9,11]. High velocities and multi-directions of turbulence flow are easily identified within post-stenotic dilatation. Contrast-enhanced RAUS shows the same findings of late-stage stenosis as well as does arteriography. US angiography can be called as computed tomography or magnetic resonance angiography. When a kidney comes to the end-stage disease, blood flow demand decreases because the kidney shrinks with irreversible renal damage. Thus, end-stage RAS becomes lower velocity of blood flow.Subsequently, the kidney size becomes markedly decreased and the cortical echogenicity becomes markedly increased.
Arteriography clearly shows the difference between late-stage RAS and intermediate-stage RAS (Table 2). Prior to intervention, radiologists and clinicians should be familiar with RAUS findings to determine kidney function. Re-hyperperfusion can facilitate renal damage in patients with late-stage RAS even if the internal diameter of an renal artery increases with angioplasty or stenting (Fig. 3) [12-14].


Atherosclerotic RAS is a multi-stage inflammatory process involving renal artery and consists of early, intermediate, and late stages. RAUS is useful in depicting characteristic imaging features according to each stage. Intermediate-stage RAS is positive on RAUS but frequently negative on arteriography. Detecting RAS prior to the late stage is of great importance in improving treatment outcome.


No potential conflict of interest relevant to this article was reported.



Conception or design: BKP.

Acquisition, analysis, or interpretation of data: BKP.

Drafting the work or revising: BKP.

Final approval of the manuscript: BKP.

Fig. 1.
Early-stage renal artery stenosis in a 61-year-old man. (A) Color Doppler ultrasound (US) axial image shows no stenosis (arrowheads) of the left renal artery orifice at systolic phase. (B) Color Doppler US axial image shows focal stenosis (arrowheads) of the left renal artery orifice at diastolic phase.
Fig. 2.
Intermediate-stage renal artery stenosis in an 80-year-old man. (A) Color Doppler ultrasound (US) axial image shows mild stenosis (arrowheads) of the left renal artery orifice at systolic phase. The internal diameter of the stenotic artery is slightly narrower than that of the post-stenotic artery (arrows). (B) Color Doppler US axial image shows severe stenosis (arrowheads) of the left renal artery orifice at diastolic phase. The internal diameter of the stenotic artery is much narrower than that of the post-stenotic artery (arrows).
Fig. 3.
Late-stage renal artery stenosis (RAS) in a 70-year-old female. (A) Spectral Doppler ultrasound (US) sagittal image shows pulsus tardus and parvus (arrows) resulting from right renal artery stenosis. Right renal perfusion is reduced, and cortical echogenicity is increased. Her glomerular filtration rate (GFR) and creatinine (Cr) were 27.8 mL/min/1.73 m2 and 1.83 mg/dL before angio-intervention, respectively. (B) Color Doppler US axial image at systolic phase shows focal stenosis (arrowheads) in the ostium of the right renal artery. (C) Color Doppler US axial image at diastolic phase shows the same degree of right RAS (arrowheads). (D) Right renal arteriography shows focal stenosis (arrowheads) in the ostium of the right renal artery. (E) Unenhanced computed tomography coronal image shows a large subcapsular hematoma (arrows) 3 days after angioplasty and stenting. Her GFR was reduced to 12.5 mL/min/1.73 m2 and her Cr was increased to 3.53 mg/dL 1 year after angioplasty and stent.
Table 1.
Diameter changes of a renal artery according to RAS stage
RAS stages Degree of RAS according to heartbeat
Clinical signs or symptoms
Systolic phase Diastolic phase
Early +
Intermediate + ++ +
Late +++ +++ +++

–, absent; +, mild; ++, moderate; +++, severe.

RAS, renal artery stenosis.

Table 2.
RAS detectability of US and arteriography according to stage
RAS stages RAS detectability of US and arteriography
Renal artery US Renal arteriography
Early +
Intermediate ++ +/–
Late +++ +++

–, absent; +, fair; ++, good; +++, excellent.

RAS, renal artery stenosis; US, ultrasound.


1. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001;344:431–42.
crossref pmid
2. Colyer WR, Eltahawy E, Cooper CJ. Renal artery stenosis: optimizing diagnosis and treatment. Prog Cardiovasc Dis 2011;54:29–35.
crossref pmid pmc
3. Weber BR, Dieter RS. Renal artery stenosis: epidemiology and treatment. Int J Nephrol Renovasc Dis 2014;7:169–81.
pmid pmc
4. Hennekens CH, Gaziano JM. Antioxidants and heart disease: epidemiology and clinical evidence. Clin Cardiol 1993;16(4 Suppl 1):I10–5.
crossref pmid
5. Baradaran A. Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathol 2012;1:126–9.
crossref pmid pmc
6. Radermacher J, Chavan A, Schaffer J, Stoess B, Vitzthum A, Kliem V, et al. Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failure. Clin Nephrol 2000;53:333–43.
7. Hua HT, Hood DB, Jensen CC, Hanks SE, Weaver FA. The use of colorflow duplex scanning to detect significant renal artery stenosis. Ann Vasc Surg 2000;14:118–24.
crossref pmid
8. Aytac SK, Yigit H, Sancak T, Ozcan H. Correlation between the diameter of the main renal artery and the presence of an accessory renal artery: sonographic and angiographic evaluation. J Ultrasound Med 2003;22:433–9.
9. Bude RO, Forauer AR, Caoili EM, Nghiem HV. Is it necessary to study accessory arteries when screening the renal arteries for renovascular hypertension? Radiology 2003;226:411–6.
crossref pmid
10. Hoffmann U, Edwards JM, Carter S, Goldman ML, Harley JD, Zaccardi MJ, et al. Role of duplex scanning for the detection of atherosclerotic renal artery disease. Kidney Int 1991;39:1232–9.
crossref pmid
11. Labropoulos N, Ayuste B, Leon LR Jr. Renovascular disease among patients referred for renal duplex ultrasonography. J Vasc Surg 2007;46:731–7.
crossref pmid
12. Chrysochou C, Cheung CM, Durow M, Middleton RJ, Solomon LR, Craig A, et al. Proteinuria as a predictor of renal functional outcome after revascularization in atherosclerotic renovascular disease (ARVD). QJM 2009;102:283–8.
crossref pmid
13. White CJ. Optimizing outcomes for renal artery intervention. Circ Cardiovasc Interv 2010;3:184–92.
crossref pmid
14. Mukherjee D. Renal artery revascularization: is there a rationale to perform? JACC Cardiovasc Interv 2009;2:183–4.
15. Li JC, Jiang YX, Zhang SY, Wang L, Ouyang YS, Qi ZH. Evaluation of renal artery stenosis with hemodynamic parameters of Doppler sonography. J Vasc Surg 2008;48:323–8.
crossref pmid
16. Grenier N, Hauger O, Cimpean A, Perot V. Update of renal imaging. Semin Nucl Med 2006;36:3–15.
crossref pmid
17. Bokhari SW, Faxon DP. Current advances in the diagnosis and treatment of renal artery stenosis. Rev Cardiovasc Med 2004;5:204–15.
18. Granata A, Fiorini F, Andrulli S, Logias F, Gallieni M, Romano G, et al. Doppler ultrasound and renal artery stenosis: an overview. J Ultrasound 2009;12:133–43.
crossref pmid pmc
19. Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen SC, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005;68:293–301.
crossref pmid


Browse all articles >


Browse all articles >

Editorial Office
Sungkyunkwan University School of Medicine
2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do 16419, Korea
Tel: +82-31-299-6038    Fax: +82-31-299-6029    E-mail: pfmjournal@skku.edu                

Copyright © 2023 by Sungkyunkwan University School of Medicine.

Developed in M2PI

Close layer
prev next